COSMO Pharmaceuticals N.V.
Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.
COPN | SW
Overview
Corporate Details
- ISIN(s):
- NL0011832936
- LEI:
- 724500OX0EBQRYTVV639
- Country:
- Netherlands
- Address:
- Sir Rogerson's Quay Riverside II, Dublin 2 Dublin
- Website:
- https://www.cosmopharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
COSMO Pharmaceuticals N.V. is a specialty pharmaceutical company focused on developing and commercializing products for gastroenterology, dermatology, and healthtech. The company's therapeutic focus is on the oral and endoscopic treatment of colon diseases, including bowel diseases and colorectal cancer prevention, utilizing its proprietary MMX® technology. In addition to its own pipeline, Cosmo provides manufacturing services to other pharmaceutical companies. These services cover the production of solid, semi-solid, and liquid oral medicines and include process assessment, technology transfer, stability testing, market release, and regulatory documentation support.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-24 02:00 |
Cosmo to Unveil First-of-its-Kind Clinical Study on the Use of GI Genius™ with …
|
English | 8.7 KB | ||
| 2025-06-24 02:00 |
Cosmo führt erste klinische Studie zur Verwendung von GI Genius™ mit Apple Visi…
|
German | 9.7 KB | ||
| 2025-05-30 02:00 |
Voting results of Cosmo’s 2025 AGM
|
English | 5.1 KB | ||
| 2025-05-30 02:00 |
Ergebnisse der Generalversammlung 2025 von Cosmo
|
German | 5.4 KB | ||
| 2025-05-05 02:00 |
Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Wee…
|
English | 6.4 KB | ||
| 2025-05-05 02:00 |
Cosmo präsentiert strategische Innovationsagenda für KI und Gastroenterologie a…
|
German | 7.1 KB | ||
| 2025-05-02 02:00 |
Cosmo Announces EU MDR Certification for Endovision’s Cerebro, expanding its re…
|
English | 10.3 KB | ||
| 2025-05-02 02:00 |
Cosmo gibt EU-MDR-Zertifizierung für Cerebro von Endovision bekannt und erweite…
|
German | 11.4 KB | ||
| 2025-04-01 02:00 |
Cosmo appoints Federico Sommariva as Chief Legal Counsel
|
English | 5.2 KB | ||
| 2025-04-01 02:00 |
Cosmo ernennt Federico Sommariva zum Chief Legal Counsel
|
German | 5.9 KB | ||
| 2025-03-06 01:00 |
Cosmo Pharmaceuticals Delivers Record 2024 Results – Completes Phase III Enroll…
|
English | 28.1 KB | ||
| 2025-03-06 01:00 |
Cosmo Pharmaceuticals mit Rekordergebnis 2024 – Abschluss der Phase-III-Rekruti…
|
German | 30.4 KB | ||
| 2025-02-12 01:00 |
Cosmo to host Investor Day on April 9, 2025
|
English | 5.3 KB | ||
| 2025-02-12 01:00 |
Cosmo lädt am 9. April 2025 zum Investorentag ein
|
German | 5.7 KB | ||
| 2025-02-11 01:00 |
Cosmo Appoints Andrea Cherubini as Chief AI Officer to Drive AI Expansion Acro…
|
English | 8.5 KB |
Automate Your Workflow. Get a real-time feed of all COSMO Pharmaceuticals N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COSMO Pharmaceuticals N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COSMO Pharmaceuticals N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
